(PharmaNewsWire.Com, February 12, 2018 ) According to a new report published by Data Bridge Market Research ‘‘Europe Radiotherapy Market’’, Europe Radiotherapy Market has accounted for USD 1.6 billion in 2016, and is expected to reach USD 2.7 billion by 2024, growing at a CAGR 6.7% during the forecast period 2017 to 2024.The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Europe Radiotherapy Market, By Therapy (Beam radiotherapy (IGRT, IMRT, VMAT, Tomotherapy, 3D CRT, Proton Beam, Stereotactic), Brachytherapy (LDR, HDR), Systemic Radiotherapy), By Product Type (Cyberknife, Gammaknife, Linac, Proton Beam, Systemic Radiotherapy, Seeds, Afterloaders), By Indication (Prostate & Breast Cancer)), By Country (Germany, France, U.K., Spain, Italy, Russia, Netherlands, Turkey, Belgium, Switzerland, Rest of Europe) – Industry Trends and Forecast to 2024
Important Segmentation For Europe Radiotherapy Market:
Europe radiotherapy market is segmented based on therapy, product, application and geography. Based on the therapy, the radiotherapy market is segmented into external beam radiotherapy, internal beam radiotherapy, and systemic radiation therapy. On the basis of radiations delivered, the external beam radiotherapy is sub segmented into intensity-modulated radiation therapy (IMRT), image guided radiotherapy (IGRT), tomotherapy, stereotactic technology, 3D conformal radiotherapy, proton beam therapy, and volumetric modulated arc therapy (VMAT). The IGRT segment is expected to account for the largest share of the external beam radiotherapy market, whereas the VMAT segment is poised to witness the highest growth. Based on the delivery of dose-rate, the internal beam therapy is divided into low (LDR) and high-dose rate (HDR). The LDR segment is expected to account for the largest share of the internal radiotherapy/brachytherapy market, whereas the HDR segment is poised to witness the highest growth.
Based on product type the Europe radiotherapy market is segmented into EBRT equipment’s, and IBRT equipment’s. The External Beam Radiotherapy (EBRT) products are further segmented into cyberknife, gammaknife, LINAC, Proton Beam (Cyclotron, Synclotron). The Internal Beam Radiotherapy (IBRT) is segmented into seeds, afterloaders and others.
Europe radiotherapy market is also segmented based on indication into cancer of different organs such as brain tumor, spine cancer, lung cancer, liver cancer, breast cancer, prostate cancer and others.
Based on geography the Europe radiotherapy market is segmented into 11 countries:
Germany, France, U.K., Italy, Spain, Russia, Turkey, Netherlands, Belgium, Switzerland and rest of Europe. Germany is expected to dominate the Europe radiotherapy market.
Competitive Analysis Of Europe radiotherapy market:
The players in Europe radiotherapy market are using mergers, acquisition and development of technology as penetration strategies. The report also includes new developments, future technological advancements, recent strategically decisions, expansions and product launches.
Top Market Competitors Of Europe radiotherapy market:
The Key Players in the Europe radiotherapy market Are:-
Medical Systems, Inc., CIVCO Medical Solutions, Elekta AB, Nanobiotix, Accuray Incorporated, Brainlab AG, Ion Beam Applications SA, C. R. Bard, Inc., IsoRay Medical, Inc., TRF, Nordion, Inc., RaySearch Laboratories AB, PRECISIS AG, Mevion Medical Systems,
Patient Monitoring Device Market: Industry Trends and Demand Forecast to 2024
Europe Patient Monitoring Device Market By Product Type, End User, Country (Germany, United Kingdom, France, Spain, Italy, Russia, Turkey, Belgium, Nether lands, Switzerland, Rest of Europe)–Industry Trends and Forecast to 2024.
This Reports Includes The Following Deliverable:
Macro Indicator Analysis Market Overview Market Dynamics Drivers, Restraints, Opportunities and Challenges Market sizing and growth analysis Market forecasting to 2024 Market Competitive Landscape Product Launches and Pipeline Analysis Value Chain Analysis Market Mergers, Acquisitions and Agreements Company Profiles
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
